Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code

2002 Vol. 20, No. 3

Cover
Display Method:
2002, (3): 131-132.
Abstract(2212) PDF (365KB)(483)
Abstract:
2002, (3): 132-133.
Abstract(1821) PDF (303KB)(495)
Abstract:
2002, (3): 134-135.
Abstract(1910) PDF (460KB)(392)
Abstract:
2002, (3): 135-135.
Abstract(1933) PDF (284KB)(437)
Abstract:
2002, (3): 136-137.
Abstract(2729) PDF (597KB)(936)
Abstract:
2002, (3): 137-140.
Abstract(1974) PDF (864KB)(547)
Abstract:
2002, (3): 140-142.
Abstract(2522) PDF (862KB)(892)
Abstract:
2002, (3): 142-143.
Abstract(2007) PDF (468KB)(793)
Abstract:
2002, (3): 144-147.
Abstract(10543) PDF (664KB)(4906)
Abstract:
2002, (3): 147-150.
Abstract:
2002, (3): 150-152.
Abstract(2322) PDF (909KB)(585)
Abstract:
Clinical observations on theraputic efficacy of domestic vs imported urapidil
DENG Li ping, DONG Yu Gang, HE Jian Gui
2002, (3): 152-154.
Abstract(2736) PDF (988KB)(467)
Abstract:
OBJECTIVE To discuss the identification and specific characterization between the domestic urapidil and the imported ebrantil through the clinical efficacy research for the patients with hypertensio METHODS The doubleblind method was selected.RESULTS...
2002, (3): 154-154.
Abstract(2278) PDF (223KB)(430)
Abstract:
2002, (3): 155-157.
Abstract(5986) PDF (835KB)(3809)
Abstract:
The study on the stability of buflomedil hydrochloride in five injection solution
ZHANG Jing-xian
2002, (3): 157-159.
Abstract:
OBJECTIVE To study the five stability of buflomedil hydrochloride in five injection solutions METHODS The content of buflomedil hydrochloride was determined by UV spectrophotometery The appearance Ph and change of buflomedil hydrochloride of UV spect...
2002, (3): 159-162.
Abstract(2174) PDF (1157KB)(1959)
Abstract:
2002, (3): 162-166.
Abstract(1915) PDF (756KB)(863)
Abstract:
2002, (3): 166-166.
Abstract(1870) PDF (168KB)(485)
Abstract:
2002, (3): 167-169.
Abstract:
2002, (3): 169-170.
Abstract(2179) PDF (490KB)(918)
Abstract:
2002, (3): 170-170.
Abstract(2087) PDF (238KB)(926)
Abstract:
The improve of the method for determination compound fluocinonide ointment
YANG Xi-Xiang, GU Li
2002, (3): 171-173.
Abstract(2529) PDF (991KB)(1028)
Abstract:
OBJECTIVE To improve the method for determination compound fluocinonide ointment.METHODS A method of RP HPLC be used, plus the internal standard after extraction and filter.ODS column (250mm×4.6mm, 5μm) was selected and the mobile phase was consisted...
2002, (3): 173-174.
Abstract(2598) PDF (734KB)(1349)
Abstract:
Assay of kanamycin and dexamethson in DICA eye drops by polarmetric analysis and ultraviolet specyrophotometry
Li Yi-qing, WANG Hai-yan, JIANG Zong-wen
2002, (3): 174-176.
Abstract(2535) PDF (673KB)(944)
Abstract:
OBJECTIVE To establish a methed for determining the concentration of kanamycin and dexamethson in DICA eye drops.METHED The concentration of kanamycin was determined by polarmetric analysis,ultravio specyro-photometry was employed for determination o...
2002, (3): 176-179.
Abstract(2263) PDF (594KB)(2644)
Abstract:
Determination of ondansetron hydrochloride in natrium chloride infusion by a reversed-phase high performance liquid chromatography
QIU Rui-gui, WANG Shi-hui
2002, (3): 179-181.
Abstract(2167) PDF (709KB)(745)
Abstract:
OBJECTIVE To establish a new method to determin ondansetron in a natrium chloride infusion.METHLDS A reversed phase high performance liquid chromatography was employed. The mobile phase was composed of methanol and 0.02M KH2PO4 solution(58:42,pH=6.0)...
2002, (3): 181-181.
Abstract(1968) PDF (181KB)(533)
Abstract:
2002, (3): 182-183.
Abstract(2338) PDF (773KB)(908)
Abstract:
2002, (3): 183-184.
Abstract(3572) PDF (973KB)(1017)
Abstract:
Cost-effectiveness analysis of three different drugs for essential hypertension
Xia La-mei, Hu De-rui
2002, (3): 185-187.
Abstract:
OBJECTIVE To evaluate the economic effectiveness of different therapeutic regimens for essential hypertension.METHODS 106 patients with first and second phase hypertension and without serious heart,brain and kidney complication were divided into 3 gr...
2002, (3): 187-187.
Abstract(1853) PDF (317KB)(459)
Abstract:
2002, (3): 188-190.
Abstract(1991) PDF (640KB)(640)
Abstract:
2002, (3): 190-191.
Abstract(2316) PDF (518KB)(532)
Abstract:
2002, (3): 191-192.
Abstract(1978) PDF (344KB)(344)
Abstract: